On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV-1 IFA test kits. The original communication indicated that CTS inventory would be exhausted by September 1, 2019 but we now have sufficient inventory to last until September 30, 2019.
Check out the Communication page for the complete details by clicking the link: Communications
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...